Philip Morris Stock: Is PM Outperforming the Consumer Staples Sector?

With a market cap of $299.1 billion, Philip Morris International Inc. (PM) is a leading global consumer goods company. The Stamford-based company operates across more than 170 markets, and its portfolio spans traditional cigarettes alongside heated tobacco, e-vapor, and oral nicotine products, including well-known brands such as Marlboro, IQOS, and ZYN.

Companies valued at $200 billion or more are typically classified as “mega-cap stocks,” and PM fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the tobacco industry. The company stands out for its powerful global brands, leadership in fast-growing smoke-free nicotine categories, and broad international reach. Its IQOS heated-tobacco platform and ZYN nicotine pouches give it strong exposure to next-generation nicotine products, while substantial investments in R&D and regulatory expertise create meaningful barriers to entry. Its global scale, established distribution network, and loyal consumer base further support pricing power, operating efficiency, and continued growth as the company shifts away from traditional cigarettes.

This tobacco titan is currently trading 9.9% below its 52-week high of $207.76, recorded on July 28. Shares of PM have soared 13% over the past three months, outpacing the State Street Consumer Staples Select Sector SPDR Fund (XLP), which climbed 2.5%. 

On a YTD basis, shares of PM are up 16.8%, compared to XLP’s 9.4% rise. In the longer term, however, PM has surged 13% over the past 52 weeks, outperforming the ETF’s 5.9% gain over the same period. 

To confirm its bullish trend, PM has been trading above its 50-day and 200-day moving averages since late April.

On Aug. 24, PM shares popped 1.7% after the company announced a contract manufacturing agreement with Altria Group, Inc.’s (MO) Philip Morris USA to leverage its cigarette manufacturing capabilities for PM’s non-U.S. operations. The arrangement, with shipments expected to begin in early 2027, aims to improve manufacturing efficiency while allowing PM to stay focused on its smoke-free transition. 

PM has notably surpassed its rival, British American Tobacco p.l.c. (BTI), which has fallen 1.2% over the past 52 weeks and 1.9% in 2026 

Looking at PM’s recent outperformance, analysts remain moderately optimistic about its prospects. The stock has a consensus rating of "Moderate Buy” from the 14 analysts covering it, and the mean price target of $206.28 suggests a 10.1% premium to its current price levels.